Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma

Fig. 2

Ex-vivo characterization of the PDAC xenograft murine model. A, B IF to evaluate GPC1 expression using AT101 and the commercial anti-GPC1 antibody as positive control, respectively. In green the signal related to GPC1 protein and in blue the nuclei. Scale bar: 25 µm. C IF to evaluate VWF expression in order to determine the presence of vascularization. In green the signal related to VWF protein and in blue the nuclei. Scale bar: 25 µm

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us